Loading clinical trials...
Loading clinical trials...
REACT Trial: A Randomized, Double Blind, Placebo-controlled, Crossover Study of Ranolazine for the Treatment of Crohn's Disease-associated Diarrhea
Conditions
Interventions
Ranolazine
Placebo
Locations
1
United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Start Date
October 18, 2022
Primary Completion Date
April 11, 2024
Completion Date
April 11, 2024
Last Updated
February 6, 2025
NCT07385807
NCT06226883
NCT05986136
NCT07207200
NCT06599658
NCT07184931
Lead Sponsor
Vanderbilt University Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions